Linifanib (ABT-869) - CAS# 796967-16-3 Size:10mg solid (and inhibition) of androgen receptor

(and inhibition) of androgen receptor

5-dimethoxyphenyl)quinazolin-2-yl)amino)-3-methylphenyl)acrylamide

Ketanserin depresses and in certain experiments reverses the vasoconstrictor response to 5-hydroxytryptamine in the perfused guinea-pig stomach

PMID: 32658637

Linifanib (ABT-869) - CAS# 796967-16-3 Size:10mg solid (and inhibition) of androgen receptorLinifanib, CAS No. 796967 16 3, also known as ABT 869, is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Linifanib inhibits members of the vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) receptor families; it exhibits much less activity against unrelated RTKs, soluble tyrosine kinases, or serine threonine kinases. This agent does not have a